Male breast carcinoma. II. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to treatment, prognostic factors and survival

Acta Oncologica
R HultbornI Ragnhult

Abstract

The complete material of male breast cancer, 166 cases, reported to the Swedish Cancer Registry in 1958-1967 is described and analyzed concerning different prognostic parameters, treatment methods and survival. Age at diagnosis, axillary lymph node status and tumour size all had significant prognostic importance in a multivariate analysis with axillary lymph node status as the strongest factor. Histologic malignancy grade was strongly correlated to axillary lymph node status and tumour size and thus to prognosis, but did not seem to be an independent prognostic factor. The primary treatment methods were quite heterogeneous and were obviously influenced by both age of the patient and clinical tumour status. No significant correlation was found between type of primary treatment and survival, but due to the retrospective nature of the study no definite conclusion could be drawn. Radical mastectomy seemed, however, to give fewer loco-regional recurrences than both modified radical mastectomy and simple mastectomy. Very few patients in the present series had received radiation therapy in adequate doses. The material gave some indications that orchiectomy might prolong survival in patients with recurrent or generalized disease.

References

Feb 1, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·P J KokB Seidel
Jul 1, 1978·Annals of Surgery·K S HellerD W Kinne
Jul 1, 1978·International Journal of Radiation Oncology, Biology, Physics·B Roswit, H Edlis
Feb 1, 1979·American Journal of Surgery·M J BrennanD E Appleby
Aug 1, 1979·Cancer·H Y YapN E Eckles
Apr 17, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·M J Duffy, G J Duffy
Jun 1, 1976·Cancer Treatment Reviews·F L MeyskensJ P Neifeld
Jul 1, 1985·British Journal of Cancer·H O AdamiL Ries
Mar 1, 1973·Archives of Surgery·W L Donegan, C M Perez-Mesa
Apr 1, 1972·Annals of Surgery·R W CrichlowW H Kearney
Jan 1, 1974·Oncology·N Walach, A Hochman
Sep 1, 1974·British Journal of Cancer·O Scheike
Feb 1, 1971·Annals of Surgery·A F Cortese, G N Cornell
Sep 1, 1969·British Journal of Cancer·P Peltokallio, T V Kalima
Apr 1, 1971·Clinical Radiology·J KirkE R Watson
Feb 1, 1969·Cancer·J S MausnerG P Rosemond
Jun 1, 1969·Cancer·H J Norris, H B Taylor
Jan 1, 1981·Journal of Surgical Oncology·S GuptaS Gupta
Jan 1, 1981·Journal of Surgical Oncology·S J RuffW S Fletcher
Jan 1, 1983·Acta Radiologica. Oncology·L E Rutqvist, A Wallgren
Jan 1, 1982·Cancer·M Lopez, A Barduagni
Nov 1, 1983·Clinical Radiology·G G Ribeiro
Feb 1, 1983·Archives of Internal Medicine·H KantarjianG Blumenschein
Jan 15, 1982·Cancer·R Robison, E D Montague
Sep 1, 1980·World Journal of Surgery·G RamantanisJ G Garas
Apr 1, 1980·The Journal of Allergy and Clinical Immunology·S R Hirsch, J H Kalbfleisch
Oct 15, 1980·Cancer·N GuptaS Raam
Feb 1, 1955·A.M.A. Archives of Surgery·C HUGGINS, G W TAYLOR
Mar 1, 1965·British Journal of Cancer·W P GREENING, P M AICHROTH
Jul 1, 1965·Annals of Surgery·J S MCLAUGHLINR W BUXTON
Mar 1, 1948·British Journal of Cancer·D H PATEY, W H DYSON

❮ Previous
Next ❯

Citations

Aug 7, 1996·International Journal of Cancer. Journal International Du Cancer·F Bessho
Jan 1, 1992·Breast Cancer Research and Treatment·M S SimonG M Swanson
Nov 22, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anuradha Chakravarthy, Choong Ryul Kim
Feb 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K J Ruddy, E P Winer
Jan 1, 1994·Acta Oncologica·T HatschekR Hultborn
Jan 1, 1994·Acta Oncologica·M A IzquierdoB Ojeda
Jan 1, 1996·Acta Oncologica·P KaramanakosD T Trafalis
Feb 21, 2006·Lancet·Ian S FentimanGabriel N Hortobagyi
May 31, 2002·Expert Opinion on Pharmacotherapy·Teresa Hayes
Jun 19, 2008·World Journal of Surgical Oncology·Kaiyumars B ContractorHemant Singhal
Mar 15, 2011·International Journal of Radiation Oncology, Biology, Physics·Edward YuPatricia Tai
Jul 11, 2012·Journal of the Egyptian National Cancer Institute·Maged M ElshafieyAmr A Attia
Nov 10, 2004·Clinical Psychology Review·Susan Nolen-Hoeksema
Oct 13, 1998·The Australian and New Zealand Journal of Surgery·H L CarmaltD J Gillett
Aug 28, 2009·Expert Opinion on Pharmacotherapy·Teresa G Hayes
Oct 26, 2016·World Journal of Clinical Oncology·Malgorzata Banys-PaluchowskiPeter Paluchowski
Sep 4, 2021·The British Journal of Surgery·A P LinK-W Tam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
H StranzlA Hackl
Ecancermedicalscience
Is Fentiman
Breast Cancer : the Journal of the Japanese Breast Cancer Society
T KanohY Morishita
© 2021 Meta ULC. All rights reserved